Menu
Live News EQUITY M impact

ABBV: Allergan Aesthetics Gets Canada Approval

Allergan Aesthetics receives approval for Boey in Canada, a rapid-onset neurotoxin for temporary improvement of frown lines

ABBV

ABBV - Allergan Aesthetics receives approval for Boey® (trenibotulinumtoxinE) in Canada, the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients